https://www.selleckchem.com/products/sgi-110.html
OBJECTIVE Juvenile dermatomyositis (JDM) is a rare disease in children that is treatable, but patients may suffer from long-term effects of the disease. Clinical trials are needed to find better treatments for affected patients. Among validated tools for evaluating disease activity clinically is the disease activity score (DAS), but it is not routinely collected in all clinics. We developed a modified DAS (DASmod) which can be scored using data routinely collected by our clinical staff, and has been used in previous studies. This study'
Like
Comment
Share
